Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium

Penelope M. Webb(QIMR Berghofer Medical Research Institute), Harvey A. Risch(University of New Haven), Elisa V. Bandera(Rutgers, The State University of New Jersey), Allan Jensen(Danish Cancer Society), Anna DeFazio(The University of Sydney), Estrid Høgdall(University of Copenhagen), Susanne K. Kjær(Copenhagen University Hospital), Marc T. Goodman(Cedars-Sinai Medical Center), Andrew Berchuck(General Marble (Greece)), Simon A. Gayther(The University of Texas Health Science Center at Houston), Britton Trabert(St. Elizabeth's Hospital), Aleksandra Gentry‐Maharaj(UCL Australia), Susan J. Ramus(Cancer Institute of New South Wales), Kathryn L. Terry(Brigham and Women's Hospital), Kirsten B. Moysich(American Cancer Society), Suzanne C. Dixon‐Suen(Cancer Council Victoria), Daniel W. Cramer(Brigham and Women's Hospital), Nicolas Wentzensen(National Cancer Institute), Joellen M. Schildkraut(Duke University Hospital), Malcolm C. Pike(Kettering University), Christina M. Nagle(The University of Queensland), Argyrios Ziogas(University of Copenhagen), Robert P. Edwards(Cancer Research UK Technology), Anna H. Wu(University of Southern California), Lisa E. Paddock(Rutgers, The State University of New Jersey), Elizabeth M. Poole(St. Elizabeth's Hospital), Jennifer A. Doherty(Cancer Prevention Institute of California), Francesmary Modugno(University of Pittsburgh), Hoda Anton‐Culver(University of California, Irvine), Usha Menon(University of South Florida), Kristine G. Wicklund(German Cancer Research Center), Alicia Beeghly‐Fadiel(University of Helsinki), Mary Anne Rossing(Fred Hutch Cancer Center), Celeste Leigh Pearce(University of Southern California), Roberta B. Ness(The University of Texas Health Science Center at Houston)
British Journal of Cancer
March 28, 2017
Cited by 21


Related Papers